Overview

An Advanced Echocardiographic Evaluation of Nebivolol

Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Nebivolol has any effect on heart function determined by changes in echocardiographic data or exercise tolerance.
Phase:
Phase 4
Details
Lead Sponsor:
Jack Rubinstein
Collaborator:
Forest Laboratories
Treatments:
Nebivolol